about
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to targ...
Read More
4.40
0.19
(4.51%)
57,253
XNAS Volume
XNAS 11 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Passage Bio Inc is on 13 May 2026 for the purpose of Passage Bio Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Passage Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..